Atyr Pharma Inc (NASDAQ: ATYR) started the day on Thursday, with a price decrease of -6.21% at $0.77, before settling in for the price of $0.82 at the close. Taking a more long-term approach, ATYR posted a 52-week range of $0.64-$7.29.
It was noted that the giant of the Healthcare sector posted annual sales growth of 34.28% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 34.28%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 5.58%. This publicly-traded company’s shares outstanding now amounts to $97.99 million, simultaneously with a float of $95.56 million. The organization now has a market capitalization sitting at $74.99 million. At the time of writing, stock’s 50-day Moving Average stood at $0.8445, while the 200-day Moving Average is $3.2865.
Atyr Pharma Inc (ATYR) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Atyr Pharma Inc’s current insider ownership accounts for 2.48%, in contrast to 63.39% institutional ownership. According to the most recent insider trade that took place on Oct 08 ’25, this organization’s Director bought 682,001 shares at the rate of 0.90, making the entire transaction reach 612,437 in total value, affecting insider ownership by 1,095,024. Preceding that transaction, on Oct 09 ’25, Company’s Director bought 317,999 for 0.94, making the whole transaction’s value amount to 299,364. This particular insider is now the holder of 1,413,023 in total.
Atyr Pharma Inc (ATYR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
Atyr Pharma Inc’s EPS increase for this current 12-month fiscal period is 5.58% and is forecasted to reach -0.56 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 13.78% through the next 5 years, which can be compared against the 34.28% growth it accomplished over the previous five years trading on the market.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Let’s observe the current performance indicators for Atyr Pharma Inc (ATYR). It’s Quick Ratio in the last reported quarter now stands at 5.93. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 394.69.
In the same vein, ATYR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.83, a figure that is expected to reach -0.18 in the next quarter, and analysts are predicting that it will be -0.56 at the market close of one year from today.
Technical Analysis of Atyr Pharma Inc (ATYR)
If we take a close look at the recent performances of Atyr Pharma Inc (NASDAQ: ATYR), its last 5-days Average volume was 1.65 million that shows plunge from its year to date volume of 4.76 million. During the previous 9 days, stock’s Stochastic %D was recorded 60.46% While, its Average True Range was 46.01.
Raw Stochastic average of Atyr Pharma Inc (ATYR) in the period of the previous 100 days is set at 1.88%, which indicates a major fall in contrast to 57.06% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0588 that was lower than 0.2307 volatility it exhibited in the past 100-days period.
